Clincosm LogoSign in Get a demo

Hepatocellular Carcinoma (HCC)

Showing 26 - 46 of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma (HCC), Solid Malignancies Trial in Worldwide (FGF401, PDR001)

Completed
Has Results
  • Hepatocellular Carcinoma (HCC)
  • Solid Malignancies
  • Los Angeles, California
  • +26 more
Nov 21, 2020

Hepatocellular Carcinoma (HCC) Trial in Worldwide (Pexastimogene Devacirepvec (Pexa Vec), Sorafenib)

Completed
Has Results
  • Hepatocellular Carcinoma (HCC)
  • Birmingham, Alabama
  • +141 more
Dec 11, 2020

Hepatocellular Carcinoma (HCC) Trial in Taiwan (nivolumab, ipilimumab)

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • nivolumab, ipilimumab
  • Kaohsiung, Taiwan
  • +7 more
Dec 2, 2020

Hepatocellular Carcinoma (HCC) Trial in Taipei (The Solero Microwave Ablation)

Withdrawn
  • Hepatocellular Carcinoma (HCC)
  • The Solero Microwave Ablation
  • Taipei, Test2, Taiwan
    National Taiwan University Hospital
Sep 10, 2020

Hepatocellular Carcinoma (HCC), Cholangiocarcinoma, Esophageal Cancer Trial in Belgium, United States (INCB062079)

Terminated
  • Hepatocellular Carcinoma (HCC)
  • +5 more
  • Birmingham, Alabama
  • +5 more
Jul 13, 2020

Hepatocellular Carcinoma (HCC) Trial in Taipei (Sonazoid- CEUS, CEMRI, CECT)

Completed
  • Hepatocellular Carcinoma (HCC)
  • Sonazoid- CEUS, CEMRI, CECT
  • Taipei, Taiwan
    National Taiwan University Hospital
Jun 29, 2020

Sorafenib Plasma Concentrations, Toxicity and Disease Control

Completed
  • Hepatocellular Carcinoma (HCC)
  • Sorafenib plasma concentration 4 weeks after treatment initiation
  • Bordeaux, France
  • +4 more
Apr 28, 2020

Hepatocellular Carcinoma (HCC) Trial in China (Lenvatinib 4 mg Oral)

Unknown status
  • Hepatocellular Carcinoma (HCC)
  • Lenvatinib 4 mg Oral
  • Hefei, Anhui, China
  • +3 more
Jan 24, 2020

Hepatocellular Carcinoma (HCC) Trial in China (Lenvima 4 mg Oral Capsule)

Unknown status
  • Hepatocellular Carcinoma (HCC)
  • Lenvima 4 mg Oral Capsule
  • Hefei, Anhui, China
  • +3 more
Jan 11, 2020

Hepatocellular Carcinoma (HCC) Trial in China (Brivanib 800 mg, QD, Brivanib 400 mg, BID)

Completed
  • Hepatocellular Carcinoma (HCC)
  • Brivanib 800 mg, QD
  • Brivanib 400 mg, BID
  • Hefei, Anhui, China
  • +14 more
Sep 3, 2019

Can Quantitative MRI After cTACE Help Predict Survival ?

Completed
  • Hepatocellular Carcinoma (HCC)
  • MRI post-TACE
  • Milwaukee, Wisconsin
    Medical College of Wisconsin/Froedtert Memorial Lutheran Hospita
Jun 6, 2019

Hepatocellular Carcinoma (HCC) Trial in Seoul (Sonazoid-enhanced ultrasonography)

Completed
  • Hepatocellular Carcinoma (HCC)
  • Sonazoid-enhanced ultrasonography
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University College of Medicine
Apr 24, 2018

TACE for HCC by TANDEM and Idarubicin

Completed
  • Hepatocellular Carcinoma (HCC)
  • Transarterial chemoembolization using TANDEM and idarubicin
  • Montpellier, France
    Uhmontpellier
Apr 23, 2018

Hepatocellular Carcinoma (HCC) Trial in Tampa, New York (Melphalan/HDS, Sorafenib)

Withdrawn
  • Hepatocellular Carcinoma (HCC)
  • Tampa, Florida
  • +1 more
Dec 14, 2017

Hepatocellular Carcinoma (HCC) Trial in Birmingham (Stereotactic Body Radiation Therapy (SBRT))

Completed
Has Results
  • Hepatocellular Carcinoma (HCC)
  • Stereotactic Body Radiation Therapy (SBRT)
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jul 13, 2017

Hepatocellular Carcinoma (HCC) Trial (Ga-68-PSMA scan, and PET -CT F-18-FDG)

Unknown status
  • Hepatocellular Carcinoma (HCC)
  • Ga-68-PSMA scan, and PET -CT F-18-FDG
  • (no location specified)
May 2, 2017

Hepatocellular Carcinoma (HCC) Trial (transarterial chemoembolization versus the standard treatment with sorafinib)

Completed
  • Hepatocellular Carcinoma (HCC)
  • transarterial chemoembolization versus the standard treatment with sorafinib
  • (no location specified)
Dec 29, 2016

Hepatocellular Carcinoma Prior to Living Donor Liver

Completed
  • Hepatocellular Carcinoma (HCC)
  • Living Donor Liver Transplantation
  • loco regional therapies for HCC
  • (no location specified)
Dec 8, 2016

Hepatocellular Carcinoma (HCC) Trial in Worldwide (brivanib (active))

Completed
  • Hepatocellular Carcinoma (HCC)
  • brivanib (active)
  • Duarte, California
  • +32 more
Sep 23, 2015

Annexin A2 asNovel Diagnostic Marker in Hepatocellular Carcinoma

Completed
  • Hepatocellular Carcinoma (HCC)
  • blood sample
  • (no location specified)
Sep 3, 2015

Hepatocellular Carcinoma (HCC) Trial in Nanning (Dendritic and Cytokine-induced Killer Cells)

Unknown status
  • Hepatocellular Carcinoma (HCC)
  • Dendritic and Cytokine-induced Killer Cells
  • Nanning, Guangxi, China
    The first Affiliated Hospital of Guangxi Medical University
Apr 11, 2013